---
document_datetime: 2025-12-02 04:56:15
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/episalvan.html
document_name: episalvan.html
version: success
processing_time: 0.1073496
conversion_datetime: 2025-12-26 10:28:03.431113
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Episalvan

[RSS](/en/individual-human-medicine.xml/65995)

##### Withdrawn

This medicine's authorisation has been withdrawn

birch bark extract Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Episalvan](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 7 June 2022, the European Commission withdrew the marketing authorisation for Episalvan (birch bark extract) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Amryt GmbH, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Episalvan was granted marketing authorisation in the EU on 14 January 2016 for the treatment of partial thickness wounds in adults.

The European Public Assessment Report (EPAR) for Episalvan is updated to indicate that the marketing authorisation is no longer valid.

Episalvan : EPAR - Summary for the public

Reference Number: EMA/785623/2015

English (EN) (247.82 KB - PDF)

**First published:** 05/02/2016

**Last updated:** 15/07/2022

[View](/en/documents/overview/episalvan-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-234)

български (BG) (296.74 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/bg/documents/overview/episalvan-epar-summary-public_bg.pdf)

español (ES) (245.78 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/es/documents/overview/episalvan-epar-summary-public_es.pdf)

čeština (CS) (287.15 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/cs/documents/overview/episalvan-epar-summary-public_cs.pdf)

dansk (DA) (244.24 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/da/documents/overview/episalvan-epar-summary-public_da.pdf)

Deutsch (DE) (250.92 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/de/documents/overview/episalvan-epar-summary-public_de.pdf)

eesti keel (ET) (242.95 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/et/documents/overview/episalvan-epar-summary-public_et.pdf)

ελληνικά (EL) (317.24 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/el/documents/overview/episalvan-epar-summary-public_el.pdf)

français (FR) (250.22 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/fr/documents/overview/episalvan-epar-summary-public_fr.pdf)

hrvatski (HR) (267.8 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/hr/documents/overview/episalvan-epar-summary-public_hr.pdf)

italiano (IT) (244.82 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/it/documents/overview/episalvan-epar-summary-public_it.pdf)

latviešu valoda (LV) (285 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/lv/documents/overview/episalvan-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (270.73 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/lt/documents/overview/episalvan-epar-summary-public_lt.pdf)

magyar (HU) (291.39 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/hu/documents/overview/episalvan-epar-summary-public_hu.pdf)

Malti (MT) (289.33 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/mt/documents/overview/episalvan-epar-summary-public_mt.pdf)

Nederlands (NL) (248.9 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/nl/documents/overview/episalvan-epar-summary-public_nl.pdf)

polski (PL) (287.6 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/pl/documents/overview/episalvan-epar-summary-public_pl.pdf)

português (PT) (246.11 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/pt/documents/overview/episalvan-epar-summary-public_pt.pdf)

română (RO) (269.5 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/ro/documents/overview/episalvan-epar-summary-public_ro.pdf)

slovenčina (SK) (287.29 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sk/documents/overview/episalvan-epar-summary-public_sk.pdf)

slovenščina (SL) (279.06 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sl/documents/overview/episalvan-epar-summary-public_sl.pdf)

Suomi (FI) (244.39 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/fi/documents/overview/episalvan-epar-summary-public_fi.pdf)

svenska (SV) (244.65 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sv/documents/overview/episalvan-epar-summary-public_sv.pdf)

Episalvan : EPAR - Risk-management-plan summary

English (EN) (225.92 KB - PDF)

**First published:** 05/02/2016

**Last updated:** 15/07/2022

[View](/en/documents/rmp-summary/episalvan-epar-risk-management-plan-summary_en.pdf)

## Product information

Episalvan : EPAR - Product Information

English (EN) (417.18 KB - PDF)

**First published:** 05/02/2016

**Last updated:** 15/07/2022

[View](/en/documents/product-information/episalvan-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-788)

български (BG) (808.66 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/bg/documents/product-information/episalvan-epar-product-information_bg.pdf)

español (ES) (404.89 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/es/documents/product-information/episalvan-epar-product-information_es.pdf)

čeština (CS) (640.06 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/cs/documents/product-information/episalvan-epar-product-information_cs.pdf)

dansk (DA) (413.47 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/da/documents/product-information/episalvan-epar-product-information_da.pdf)

Deutsch (DE) (432.51 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/de/documents/product-information/episalvan-epar-product-information_de.pdf)

eesti keel (ET) (398.81 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/et/documents/product-information/episalvan-epar-product-information_et.pdf)

ελληνικά (EL) (843.43 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/el/documents/product-information/episalvan-epar-product-information_el.pdf)

français (FR) (426.81 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/fr/documents/product-information/episalvan-epar-product-information_fr.pdf)

hrvatski (HR) (494.83 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/hr/documents/product-information/episalvan-epar-product-information_hr.pdf)

íslenska (IS) (412.08 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/is/documents/product-information/episalvan-epar-product-information_is.pdf)

italiano (IT) (413.48 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/it/documents/product-information/episalvan-epar-product-information_it.pdf)

latviešu valoda (LV) (676.12 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/lv/documents/product-information/episalvan-epar-product-information_lv.pdf)

lietuvių kalba (LT) (503.12 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/lt/documents/product-information/episalvan-epar-product-information_lt.pdf)

magyar (HU) (653.64 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/hu/documents/product-information/episalvan-epar-product-information_hu.pdf)

Malti (MT) (668.13 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/mt/documents/product-information/episalvan-epar-product-information_mt.pdf)

Nederlands (NL) (420.11 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/nl/documents/product-information/episalvan-epar-product-information_nl.pdf)

norsk (NO) (409.62 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/no/documents/product-information/episalvan-epar-product-information_no.pdf)

polski (PL) (672.77 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/pl/documents/product-information/episalvan-epar-product-information_pl.pdf)

português (PT) (413.49 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/pt/documents/product-information/episalvan-epar-product-information_pt.pdf)

română (RO) (513.12 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/ro/documents/product-information/episalvan-epar-product-information_ro.pdf)

slovenčina (SK) (659.65 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sk/documents/product-information/episalvan-epar-product-information_sk.pdf)

slovenščina (SL) (633.51 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sl/documents/product-information/episalvan-epar-product-information_sl.pdf)

Suomi (FI) (464.57 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/fi/documents/product-information/episalvan-epar-product-information_fi.pdf)

svenska (SV) (412.87 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sv/documents/product-information/episalvan-epar-product-information_sv.pdf)

07/06/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Episalvan : EPAR - All Authorised presentations

English (EN) (224.16 KB - PDF)

**First published:** 05/02/2016

**Last updated:** 15/07/2022

[View](/en/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-271)

български (BG) (213.15 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/bg/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_bg.pdf)

español (ES) (179.64 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/es/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_es.pdf)

čeština (CS) (206.85 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/cs/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (178.94 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/da/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (179.35 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/de/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (179.37 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/et/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (214.3 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/el/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_el.pdf)

français (FR) (178.46 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/fr/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (192.58 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/hr/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (184.82 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/is/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_is.pdf)

italiano (IT) (180 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/it/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (238.07 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/lv/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (197.73 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/lt/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (204.56 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/hu/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (207.5 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/mt/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (179.14 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/nl/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (184.87 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/no/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_no.pdf)

polski (PL) (206.18 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/pl/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_pl.pdf)

português (PT) (179.38 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/pt/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_pt.pdf)

română (RO) (196.46 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/ro/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (206.29 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sk/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (200.6 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sl/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (180.06 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/fi/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (180.74 KB - PDF)

**First published:**

05/02/2016

**Last updated:**

15/07/2022

[View](/sv/documents/all-authorised-presentations/episalvan-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Episalvan Active substance Betulae cortex International non-proprietary name (INN) or common name birch bark extract Therapeutic area (MeSH)

- Wounds and Injuries
- Wound Healing

Anatomical therapeutic chemical (ATC) code D03AX13

### Pharmacotherapeutic group

Preparations for treatment of wounds and ulcers

### Therapeutic indication

Treatment of partial thickness wounds in adults. See sections 4.4 and 5.1 in Product Information with respect to type of wounds studied.

## Authorisation details

EMA product number EMEA/H/C/003938 Marketing authorisation holder

Amryt AG

Streiflingsweg 11

Opinion adopted 19/11/2015 Marketing authorisation issued 14/01/2016 Withdrawal of marketing authorisation 07/06/2022 Revision 7

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Episalvan : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (327.1 KB - PDF)

**First published:** 16/03/2017

**Last updated:** 15/07/2022

[View](/en/documents/procedural-steps-after/episalvan-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Episalvan : EPAR - Public assessment report

Adopted

Reference Number: EMA/833320/2015

English (EN) (5.7 MB - PDF)

**First published:** 05/02/2016

**Last updated:** 15/07/2022

[View](/en/documents/assessment-report/episalvan-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for Episalvan

Adopted

Reference Number: EMA/765144/2015

English (EN) (233.95 KB - PDF)

**First published:** 20/11/2015

**Last updated:** 15/07/2022

[View](/en/documents/smop-initial/chmp-summary-opinion-episalvan_en.pdf)

#### News on Episalvan

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 November 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-16-19-november-2015) 20/11/2015

**This page was last updated on** 15/07/2022

## Share this page

[Back to top](#main-content)